Skip to main content


Clinical Research

Current clinical trials at site:

  • NATRON (D3254C00001) / Phase III / Indication: Hypereosinophilic Syndrome (HES) / Sponsor: AstraZeneca
  • ROR-PH-303 / Phase III / Indication: Pulmonary Arterial Hypertension (PAH) / Sponsor: United Therapeutics
  • EXPOSURE / NIS / Indication: Pulmonary Arterial Hypertension (PAH) / Sponsor: Actelion Pharm. Ltd. (Janssen Pharm. / J&J)
  • ASCENT (D5180R00011) / NIS / Indication: Severe Asthma / Sponsor: AstraZeneca
  • ENDURA-2 (222725) / Phase III / Indication: COPD / Sponsor: GlaxoSmithKline (GSK)
  • PALM-ILD (INS1009-311) / Phase III / Indication: PH-ILD / Sponsor Insmed Inc.